Impact of chromosome 2 obesity loci on cardiovascular complications of insulin resistance in LDL receptor-deficient C57BL/6 mice

Diabetes

Volumn 55, Issue 8, 2006, Pages 2265-2271

  Estrada Smith, Daria ^a,c   Collins, Alan R ^b   Wang, Xuping ^b   Crockett, Craig ^a   Castellani, Lawrence ^b   Lusis, Aldons J ^a,b   Davis, Richard C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

AUC, area under the curve; NMR, nuclear magnetic resonance

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHROMOSOME 2; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; WEIGHT GAIN; ANIMAL; ATHEROSCLEROSIS; BLOOD; BREEDING; C57BL MOUSE; CHROMOSOME; CHROMOSOME MAP; GENETIC PREDISPOSITION; GENETICS; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; PHYSIOLOGY;

ALLELES; ANIMALS; ATHEROSCLEROSIS; BLOOD GLUCOSE; BREEDING; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHROMOSOME MAPPING; CHROMOSOMES; CHROMOSOMES, MAMMALIAN; GENETIC PREDISPOSITION TO DISEASE; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIAS; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; OBESITY; RECEPTORS, LDL;

EID: 33749370103     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0377     Document Type: Article

References (30)

1. Reaven GM: Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44:121-131, 1993
2. Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 48:1684-1699, 2005
3. Ferrannini E, Haffner SM, Mitchell BD, Stern MP: Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422, 1991
4. Laakso M, Sarlund H, Mykkanen L: Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 10:223-231, 1990
5. Golden SH, Folsom AR, Coresh J, Sharrett AR, Szklo M, Brancati F: Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the Atherosclerosis Risk in Communities study. Diabetes 51:3069-3076, 2002
6. Wang X, Ishimori N, Korstanje R, Rollins J, Paigen B: Identifying novel genes for atherosclerosis through mouse-human comparative genetics. Am J Hum Genet 77:1-15, 2005
7. Estrada-Smith D, Castellani LW, Wong H, Wen PZ, Chui A, Lusis AJ, Davis RC: Dissection of multigenic obesity traits in congenic mouse strains. Mamm Genome 15:14-22, 2004
8. Collins AR, Meehan WP, Kintscher U, Jackson S, Wakino S, Noh G, Palinski W, Hsueh WA, Law RE: Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 21:365-371, 2001
9. Merat S, Casanada F, Sutphin M, Palinski W, Reaven PD: Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler Thromb Vasc Biol 19:1223-1230, 1999
10. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J: Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 92:883-893, 1993
11. Qiao JH, Welch CL, Xie PZ, Fishbein MC, Lusis AJ: Involvement of the tyrosinase gene in the deposition of cardiac lipofuscin in mice: association with aortic fatty streak development. J Clin Invest 92:2386-2393, 1993
12. Mehrabian M, Qiao, J-H, Hyman R, Ruddle D, Laughton C, Lusis AJ: Influence of the apolipoprotein A-II gene locus on HDL levels and fatty streak development in mice. Arterioscler Thromb 13:1-10, 1993
13. Schreyer SA, Wilson DL, LeBoeuf RC: C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 136:17-24, 1998
14. Taicher GZ, Tinsley FC, Reiderman A, Heiman ML: Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis. Anal Bioanal Chem 377:990-1002, 2003
15. Mosier HD, Crinella FM, Yu J, Culler FC, Jansons RA: Food efficiency in rats following brain lesions which affect target body size: implications on the set point for target size. Growth Dev Aging 57:223-231, 1993
16. Simha V, Garg A: Lipodystrophy: lessons in lipid and energy metabolism. Curr Opin Lipidol 17:162-169, 2006
17. Lavelle-Jones M, Scott MH, Kolterman O, Moossa AR, Olefsky JM: Non-insulin-mediated glucose uptake predominates in postabsorptive dogs. Am J Physiol 252:E660-E666, 1987
18. Meneilly GS, McIntosh CH, Pederson RA, Habener JF, Ehlers MR, Egan JM, Elahi D: Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes. Diabetes Care 26:837-842, 2003
19. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126, 1999
20. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE: Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43:1498-1506, 2000
21. Fujimoto K, Shibasaki T, Yokoi N, Kashima Y, Matsumoto M, Sasaki T, Tajima N, Iwanaga T, Seino S: Piccolo, a Ca2+ sensor in pancreatic beta-cells: involvement of cAMP-GEFII.Rim2.Piccolo complex in cAMP-dependent exocytosis. J Biol Chem 277:50497-50502, 2002
22. Muharram G, Beucher A, Moerman E, Belaich S, Gmyr V, Vandewalle B, Pattou F, Kerr-Conte J: Endocrine pancreatic tissue plasticity in obese humans is associated with cytoplasmic expression of PBX-1 in pancreatic ductal cells. Biochem Biophys Res Commun 333:1153-1159, 2005
23. Sagen JV, Baumann ME, Salvesen HB, Molven A, Sovik O, Njolstad PR: Diagnostic screening of NEUROD1 (MODY6) in subjects with MODY or gestational diabetes mellitus. Diabet Med 22:1012-1015, 2005
24. Hansen SK, Rose CS, Glumer C, Drivsholm T, Borch-Johnsen K, Jorgensen T, Pedersen O, Hansen T: Variation near the hepatocyte nuclear factor (HNF)-4alpha gene associates with type 2 diabetes in the Danish population. Diabetologia 48:452-458, 2005
25. Pearson ER, Pruhova S, Tack CJ, Johansen A, Castleden HA, Lumb PJ, Wierzbicki AS, Clark PM, Lebl J, Pedersen O, Ellard S, Hansen T, Hattersley AT: Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia 48:878-885, 2005
26. Chiu CH, Lin WD, Huang SY, Lee YH: Effect of a C/EBP gene replacement on mitochondrial biogenesis in fat cells. Genes Dev 18:1970-1975, 2004
27. Roy SK, Hu J, Meng Q, Xia Y, Shapiro PS, Reddy SP, Platanias LC, Lindner DJ, Johnson PF, Pritchard C, Pages G, Pouyssegur J, Kalvakolanu DV: MEKK1 plays a critical role in activating the transcription factor C/EBP-beta-dependent gene expression in response to IFN-gamma. Proc Natl Acad Sci U S A 99:7945-7950, 2002
28. Pletcher MT, McClurg P, Batalov S, Su AI, Barnes SW, Lagler E, Korstanje R, Wang X, Nusskern D, Bogue MA, Mural RJ, Paigen B, Wiltshire T: Use of a dense single nucleotide polymorphism map for in silico mapping in the mouse. PloS Biol 2:e393, 2004
29. Cervino AC, Li G, Edwards S, Zhu J, Laurie C, Tokiwa G, Lum PY, Wang S, Castellini LW, Lusis AJ, Carlson S, Sachs AB, Schadt EE: Integrating QTL and high-density SNP analyses in mice to identify Insig2 as a susceptibility gene for plasma cholesterol levels. Genomics 86:505-517, 2005
30. Davis RC, Schadt EE, Cervino AC, Peterfy M, Lusis AJ: Ultrafine mapping of SNPs from mouse strains C57BL/6J, DBA/2J, and C57BLKS/J for loci contributing to diabetes and atherosclerosis susceptibility. Diabetes 54:1191-1199, 2005